Question 1

What is ELTROMBOPAG OLAMINE used for?

Accepted Answer

ELTROMBOPAG OLAMINE (brand name eltrombopag) is a Other indicated for immunoglobulins, immunoglobulins.

Question 2

How does ELTROMBOPAG OLAMINE work?

Accepted Answer

ELTROMBOPAG OLAMINE works through the following mechanism: 12.2 Pharmacodynamics In clinical trials, treatment with eltrombopag resulted in dose-dependent increases in platelet counts following repeated (daily) dosing. The increase in platelet counts reached a maximum approximately two weeks after the initiation of dosing, and returned to baseline within approximately two weeks after the last dose of eltrombopag. Cardiac Electrophysiology At doses up to 150 mg (the maximum recommended dose) daily for 5 days, eltrombopag did not prolong the QT/QTc interv.

Question 3

What are the most common side effects of ELTROMBOPAG OLAMINE?

Accepted Answer

Reported side effects vary by individual. The side-effects section on this page lists the events most frequently reported to FDA FAERS for ELTROMBOPAG OLAMINE. FAERS is voluntary reporting, so it reflects what was reported, not absolute incidence.

Question 4

Is ELTROMBOPAG OLAMINE the same as eltrombopag?

Accepted Answer

eltrombopag is a brand name for ELTROMBOPAG OLAMINE. They share the same active ingredient and FDA-approved indications. Biosimilars and authorised generics may differ in inactive ingredients such as buffers or preservatives.

ELTROMBOPAG OLAMINE

Mechanism of Action

Indications

FDA Warnings

Known Side Effects

Community Discussions

Primary sources

Compare With

Formulations